Patient Pathfinder: Clinical Trials
Clinical Trials for Ovarian Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 439 active Ovarian Cancer trials
ADP-A2M4CD8 Monotherapy and in Combination With Nivolumab in HLA-A2+ Subjects With MAGE-A4 Positive Ovarian Cancer (SURPASS-3)
Study Type: Interventional Phase 2
Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer
Study Type: Interventional Phase 1
A Study of FRaDCs for Ovarian Cancer
Study Type: Interventional Phase 1
A Study to Prevent and Improve Sexual Health Concerns for People With Breast Cancer
Study Type: Interventional
89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors
Study Type: Interventional Phase 2
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
Study Type: Interventional Phase 2
Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers
Study Type: Interventional Phase 1
Ovarian Tissue Cryopreservation for Fertility Preservation
Study Type: Observational
There are 439 active Ovarian Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now